Numerous epidemiological studies have shown associations between exposure to particulate air pollution and acute increases in morbidity and mortality, particularly in persons with chronic obstructive pulmonary disease. The dosimetry of ultrafine particles in the human lung is poorly characterized. We studied the deposition and clearance of an ultrafine technetium-99m labeled aerosol in 10 patients with chronic obstructive pulmonary disease and 9 healthy subjects. Particle retention was followed for 2 hours post-inhalation and again at 24 hours by gamma scintigraphy. Central-to-peripheral ratios indexed airway deposition. Particle accumulation in the liver was examined by quantifying activity below the right lung. The dose rate for an aerosol exposure of 10 ug/m3 was calculated. Patients had a significantly greater dose rate than healthy subjects (2.9±1.0 vs.
Introduction
A fair amount of data on the deposition of ultrafine parti cles in healthy volunteers is available. However, ultrafine deposition data for the diseased lung are limited to five chronic obstructive pulmonary disease (COPD) patients and three restrictive lung disease patients studied by Anderson and colleagues. Data for ultrafine particle clearance from the human lung are far more limited. The purpose of our study was to characterize the deposition and clearance of a technetium-99m-labeled ultrafine aerosol in patients with COPD and healthy age-matched volunteers.
Conclusions
We have found that patients with moderate to severe COPD have an increased Drate of 54% relative to healthy subjects. Some of this increased deposition occurs in the airways, although most likely occurs in the parenchymal lung. Given that these patients have heterogeneous ventilation within their lungs, they may receive a tissue dose to the parenchymal lung that is many times that occurring in the healthy lung. We found no evidence of the rapid pulmonary clearance of these insoluble, carbon ultrafine particles into the circulation. The increased tissue dose received by COPD patients may contribute to systemic effects as a result of an exacerbation of their airway inflammation and cytokine release into circulation, but not the rapid movement of significant number of insoluble particles into the circulation.
Exposure to ambient particulate matter is associated with increased morbidity/mortality in respiratory/ cardiovascular disease.
Toxicity of ultrafine particles is greater than fine particles composed of same material.
Rapid translocation of ultrafine particles into the blood?
Background
Healthy (n=9) COPD ( Ultrafine Aerosol Inhalation (carbon-Tc-99m)
• 60 nm (σ g =2) aggregates, primary particles 22 nm (σ g =1.2)
• Natural breath pattern (measured previously by Respitrace)
• Retention followed for 2 hours by gamma camera 
